Document is current
Any future updates will be listed below
-
Authors
Abreu-Mota, Tiago https://orcid.org/0000-0002-0891-4734
Hagen, Katie R.
Cooper, Kurt
Jahrling, Peter B.
Tan, Gene
Wirblich, Christoph
Johnson, Reed F.
Schnell, Matthias J.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI105204-05, Intramural)
- License Information
-
More Information
Article History
Received: 18 May 2018
Accepted: 10 September 2018
First Online: 11 October 2018
Competing interests
: T.A.-M, P.B.J., and M.J.S. are inventors on the U.S. Provisional Patent Application No. 62/691,413 (Title: Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever). All remaining authors declare no competing interests.
